Clinical Trial Update: A Study to Evaluate of the Safety and Effectiveness of Asoprisnil in Treating Women With Uterine Fibroids [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating the safety and effectiveness of Asoprisnil in women with uterine fibroids has completed. The sponsor of the study was Abbott.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Leiomyoma
• Menorrhagia
• Metrorrhagia
• Uterine Fibroids

Drugs mentioned

• Asoprisnil (asoprisnil)

Snippet

Sponsor: Abbott | Conditions: Fibroid Uterus, Leiomyoma | Phase 3 | Status: COMPLETED